Development of an unconventional in vitro drug release test method for a bile acid sequestrant, DMP 504, tablet.
Wu
L S
LS
DuPont Pharmaceuticals Company, Experimental Station, Wilmington, Delaware 19880-0400, USA. lei-shu.wu@dupontpharma.com
McCormick
T J
TJ
Chang
R K
RK
Pang
J
J
McCummings
T
T
Ramos
M
M
Hussain
M A
MA
D000924:Anticholesteremic Agents / Q000737:chemistry; D001647:Bile Acids and Salts / Q000378:metabolism*; D002138:Calibration; D002626:Chemistry, Pharmaceutical; D002792:Cholestyramine Resin / Q000737:chemistry; D003084:Colestipol / Q000737:chemistry; D000960:Hypolipidemic Agents / Q000737:chemistry*; D016014:Linear Models; D011108:Polymers / Q000737:chemistry*; D000644:Quaternary Ammonium Compounds / Q000737:chemistry*; D013607:Tablets
D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; C111415:DMP-504; D000960:Hypolipidemic Agents; D011108:Polymers; D000644:Quaternary Ammonium Compounds; D013607:Tablets; D002792:Cholestyramine Resin; D003084:Colestipol